
About Beina Gene
Beina Gene is a Healthcare company based in Wuhan (China) founded in 2012 by Song Chi. Nanopore sequencing and bioinformatics analysis technologies are developed. Beina Gene has raised $3.93 million across 1 funding round from investors including Ruijiang Kangsheng Fund. Its chief executive, as recorded, is Song Chi. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Suite.
Company details
Beina Gene was founded in 2012 in Wuhan, China, within the biotechnology sector. Nanopore sequencing technologies are developed for medical diagnostics of pathogenic microorganisms and scientific research applications. Bioinformatics analysis is integrated to support products in animal and plant genomics, microbial metagenomics, and direct RNA sequencing. A record data output of 18.36G on a single chip was set by the direct RNA sequencing product.
- Headquarters Wuhan, China
- Founders Song Chi
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website benagen.com
- Total Equity Funding$3.93M (USD)
in 1 rounds
- Latest Funding Round$3.93M (USD), Seed
Dec 2021
Funding Insights of Beina Gene
Beina Gene has successfully raised a total of $3.93M through 1 strategic funding round. The most recent funding activity was a Seed round of $3.93 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.93M
- Total Rounds 1
- Last Round Seed β $3.93M
- First Round $3.93M
(Dec 2021)
- Investors Count 1
All 1 funding rounds of Beina Gene with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $3.93M | Seed | β | Ruijiang Kangsheng Fund | β |
1 investors in total: 1 institutional.
Investors in Beina Gene
Beina Gene has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ruijiang Kangsheng Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investor details for Beina Gene
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Beina Gene
1 people are tracked at Beina Gene (1 in leadership).
| Name | Role | Group |
|---|---|---|
Song Chi | Founder & CEO | Leadership |
Complete people profiles for Beina Gene
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Beina Gene
2 dated milestones of Beina Gene across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Beina Gene is founded.
- Funding First funding round of $3.9M.
Web traffic of Beina Gene
The website of Beina Gene (benagen.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▼ 26.8% vs previous month
Websites whose visitors overlap most with Beina Gene. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ieda.org.cn | ieda.org.cn | 100% | #9,841,371 | β | |
tinygene.com | tinygene.com | 99% | β | ||
genetics.ac.cn | genetics.ac.cn | 99% | #765,948 | β | |
gdim.cn | gdim.cn | 87% | β | ||
| biomarker.com.cn | 86% | 1.8K | #9,298,532 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 31 similar websites and full traffic analytics for Beina Gene
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 31 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Beina Gene
Complete news archive for Beina Gene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beina Gene
Beina Gene was founded in 2012 and raised its 1st funding round 9 years after it was founded.
Beina Gene is headquartered in Wuhan, China. It is registered at Wuhan, Hubei, China.
Song Chi is the CEO of Beina Gene, as recorded in our data. They have also founded this company.
Beina Gene is a funded company, having raised a total of $3.93M across 1 funding round to date. The company's 1st funding round was a Seed of $3.93M, raised on Dec 2021.
Beina Gene was founded in 2012 in Wuhan, China, within the biotechnology sector. Nanopore sequencing technologies are developed for medical diagnostics of pathogenic microorganisms and scientific research applications. Bioinformatics analysis is integrated to support products in animal and plant genomics, microbial metagenomics, and direct RNA sequencing. A record data output of 18.36G on a single chip was set by the direct RNA sequencing product.
Beina Gene has 1 investor. Key investors include Ruijiang Kangsheng Fund.
